News

Atossa Therapeutics' Upcoming Financial Results Conference Call

Atossa Therapeutics' Upcoming Financial Results Conference Call

Atossa Therapeutics to Host Financial Results Conference Call

Atossa Therapeutics, Inc. (Nasdaq: ATOS) is preparing to share its financial results for the fourth quarter and the entire year of 2024. This Seattle-based biopharmaceutical company, known for its dedication to innovating treatments for breast cancer, has announced an important date for its investors. The eagerly anticipated conference call will occur on a Tuesday morning, at 8:30 a.m. ET.

Details of the Conference Call

During this live audio webcast, the executives from Atossa Therapeutics will cover critical corporate updates and delve into financial details that matter to their stakeholders. Tune in online through the investor relations section on the company’s website, ensuring that all interested parties have the opportunity to gain insights into the company’s progress and future plans.

An Opportunity for Stakeholders

Investors and other parties interested in the financial health of Atossa are encouraged to participate in this call. Following the live discussion, there will also be a replay available for those who cannot attend at the scheduled time. This replay will remain accessible for an entire 30 days, providing ample time for stakeholders to acquaint themselves with the company’s developments.

Innovative Solutions for Breast Cancer Treatment

Atossa Therapeutics stands out in the biopharmaceutical realm with its commitment to transforming the landscape of breast cancer treatment. They are notably advancing a product candidate known as (Z)-endoxifen, which has shown great promise as a selective estrogen receptor modulator (SERM). This medication aims to target various breast cancer stages—ranging from preventive to advanced cases—demonstrating Atossa's robust clinical approach.

About the Company

As a clinical-stage company listed on Nasdaq under the ticker ATOS, Atossa has dedicated itself to innovative research aimed at improving patient outcomes. Their strong focus on patient-centered solutions not only fosters a healthier tomorrow for patients but also creates sustainable shareholder value. This strategic approach signifies their operational ethos and dedication to enhancing breast cancer treatments.

Commitment to Patient Care

Atossa's journey reflects a deep commitment to scientific advancement and patient care. By focusing on developing effective treatments, the company aims to revolutionize how breast cancer is addressed, ensuring that patients receive the best possible therapies tailored to their needs.

Company Contact Information

For further inquiries, investors and interested parties can reach out to Michael Parks, the Vice President of Investor and Public Relations at Atossa Therapeutics. His contact number is 484-356-7105 and email address is michael.parks@atossainc.com. This communication highlights Atossa’s openness to dialogue and transparency with its stakeholders.

Frequently Asked Questions

What is the date of Atossa's financial results conference call?

The conference call is scheduled for a Tuesday morning at 8:30 a.m. ET.

Where can I access the conference call?

The call can be accessed via the investor relations section of the Atossa Therapeutics website.

What product candidate is Atossa focusing on?

Atossa is focusing on (Z)-endoxifen, a potent SERM aimed at various breast cancer stages.

How long will the conference call replay be available?

A replay of the conference call will be available for 30 days after the initial event.

Who can I contact for more information about Atossa?

Michael Parks, VP of Investor and Public Relations, can be contacted at 484-356-7105 or michael.parks@atossainc.com.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 154

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 197

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 101

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading
Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

Updated Category News Views 227

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

Continue Reading
Layne's Chicken Fingers Expands with Brownsville Opening

Updated Category News Views 16

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Continue Reading
BTQ Technologies Calls Investors for Key Quantum Update

Updated Category News Views 127

You know what's stirring the pot over at BTQ Technologies? A shareholder call coming up soon, and boy, it's got 'eye-opening insights' written all over it. We're talkin' Q3 financial results and, likely, a smattering of future plans on the quantum front, folks. Diving into BTQ's Quantum Vision BTQ Technologies Corp. (NASDAQ: BTQ) isn't just another tech firm banging on...

Continue Reading
ManuTech Center Set to Revolutionize Manufacturing Hub

Updated Category News Views 124

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

Continue Reading
Ecopetrol Sidesteps Hefty Fines After Investigation Closure

Updated Category News Views 130

Colombian Watchdog Gives Ecopetrol a Pass It's like dodging a bullet in a duel at high noon. The Superintendency of Industry and Commerce (SIC) has finally closed its investigation into Ecopetrol S.A. and its subsidiaries, CENIT and OCENSA, after a probe two years in the making. The stakes were sky-high, folks. We're talkin' about just shy of 530 billion Colombian pesos...

Continue Reading
Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 141

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading
KeyCorp Plans Redemption of Series E Preferred Stock

Updated Category News Views 112

KeyCorp Drops a Major Redemption Bombshell Out of the blue, KeyCorp (NYSE: KEY) just tossed a curveball at investors with the announcement they’re redeeming every last one of their Series E Fixed-to-Floating Rate Perpetual Non-Cumulative Preferred Stock shares come December 15, 2026. This move is bound to stir the pot a bit even if you’ve been around the block a few...

Continue Reading

Top 5 Most Recently Viewed Articles

Pyramid Global Hospitality Welcomes Anthony Torres Amid Award Success

Updated Category News Views 281

Pyramid Global Hospitality Welcomes a New Leader The renowned hospitality management company, Pyramid Global Hospitality, has recently appointed Anthony Torres as its vice president of food and beverage. In this pivotal role, he will oversee the culinary vision that has underpinned the company’s award-winning reputation in the hospitality industry. Celebrating Culinary...

Continue Reading
Shamari Reid's Audiobook Earns Audie Award Nomination

Updated Category News Views 117

Shamari Reid's Audiobook Earns Audie Award Nomination Heinemann, a respected name in educational publishing, has announced that Shamari Reid's audiobook, Humans Who Teach: A Guide for Centering Love, Justice, and Liberation in Schools, has been nominated for the prestigious Audie Award in the business and personal development category. This recognition highlights the...

Continue Reading
Azazie's Summer RSVP Collection: Versatility Unleashed

Updated Category News Views 19

The Shift from Singular to Seasonal Dressing You ever get that feeling when you’re dressing for a season full of events, rather than pinning everything on just one big day? That’s what Azazie’s latest move is about, tearing up those old pages of the calendar marked just for weddings and making room for the whole shebang—every lunch, night out, and festive fling...

Continue Reading
Growing Demand for Automated Boarding Gates: Market Trends

Updated Category News Views 197

Overview of the Automatic Boarding Gates Market The automatic boarding gates market is on the rise, with expectations to reach $132.8 million by the end of the forecast period in 2032. Key factors driving this growth include an increase in air passenger traffic, ongoing technological advancements, and heightened security needs in the industry. A recent report shows that...

Continue Reading
Stride, Inc.'s Compliance Issues Under Investigation by SEC

Updated Category News Views 330

Stride, Inc. Faces Serious Investor Scrutiny Shares of Stride, Inc. (NYSE: LRN), a notable player in the educational technology sector, have seen a sharp decline in value due to recent allegations made against the company. The complaints, originating from a New Mexico school district, allege serious infractions, including fraudulent practices and conflicts of interest,...

Continue Reading